These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 39130746)

  • 1. Systematic profiling of mitochondria-related transcriptome in tumorigenesis, prognosis, and tumor immune microenvironment of intrahepatic cholangiocarcinoma: a multi-center cohort study.
    Chen B; Lu M; Chen Q; Zou E; Bo Z; Li J; Zhao R; Zhao J; Yu Z; Chen G; Wu L
    Front Genet; 2024; 15():1430885. PubMed ID: 39130746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Machine Learning-based Development and Validation of a Cell Senescence Predictive and Prognostic Signature in Intrahepatic Cholangiocarcinoma.
    Yang R; Sun F; Shi Y; Wang H; Fan Y; Wu Y; Fan R; Wu S; Sun L
    J Cancer; 2024; 15(9):2810-2828. PubMed ID: 38577599
    [No Abstract]   [Full Text] [Related]  

  • 3. Comprehensive analysis of genomic mutation signature and tumor mutation burden for prognosis of intrahepatic cholangiocarcinoma.
    Zhang R; Li Q; Fu J; Jin Z; Su J; Zhang J; Chen C; Geng Z; Zhang D
    BMC Cancer; 2021 Feb; 21(1):112. PubMed ID: 33535978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and validation of a lactate metabolism-related six-gene prognostic signature in intrahepatic cholangiocarcinoma.
    Sang C; Yan L; Lin J; Lin Y; Gao Q; Shen X
    J Cancer Res Clin Oncol; 2024 Apr; 150(4):199. PubMed ID: 38627278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FASN-mediated fatty acid biosynthesis remodels immune environment in Clonorchis sinensis infection-related intrahepatic cholangiocarcinoma.
    Xu L; Zhang Y; Lin Z; Deng X; Ren X; Huang M; Li S; Zhou Q; Fang F; Yang Q; Zheng G; Chen Z; Wu Z; Sun X; Lin J; Shen J; Guo J; Li X; Xue T; Tan J; Lin X; Tan L; Peng H; Shen S; Peng S; Li S; Liang L; Cleary JM; Lai J; Xie Y; Kuang M
    J Hepatol; 2024 Aug; 81(2):265-277. PubMed ID: 38508240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring the role of tumor stemness and the potential of stemness-related risk model in the prognosis of intrahepatic cholangiocarcinoma.
    Yue Y; Tao J; An D; Shi L
    Front Genet; 2022; 13():1089405. PubMed ID: 36712866
    [No Abstract]   [Full Text] [Related]  

  • 7. A metabolism-related 4-lncRNA prognostic signature and corresponding mechanisms in intrahepatic cholangiocarcinoma.
    Zou W; Wang Z; Wang F; Li L; Liu R; Hu M
    BMC Cancer; 2021 May; 21(1):608. PubMed ID: 34034689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multimodal single-cell profiling of intrahepatic cholangiocarcinoma defines hyperactivated Tregs as a potential therapeutic target.
    Alvisi G; Termanini A; Soldani C; Portale F; Carriero R; Pilipow K; Costa G; Polidoro M; Franceschini B; Malenica I; Puccio S; Lise V; Galletti G; Zanon V; Colombo FS; De Simone G; Tufano M; Aghemo A; Di Tommaso L; Peano C; Cibella J; Iannacone M; Roychoudhuri R; Manzo T; Donadon M; Torzilli G; Kunderfranco P; Di Mitri D; Lugli E; Lleo A
    J Hepatol; 2022 Nov; 77(5):1359-1372. PubMed ID: 35738508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ESR1 as a recurrence-related gene in intrahepatic cholangiocarcinoma: a weighted gene coexpression network analysis.
    Li F; Chen Q; Yang Y; Li M; Zhang L; Yan Z; Zhang J; Wang K
    Cancer Cell Int; 2021 Apr; 21(1):225. PubMed ID: 33865377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial-Related Transcriptome Feature Correlates with Prognosis, Vascular Invasion, Tumor Microenvironment, and Treatment Response in Hepatocellular Carcinoma.
    Wang Y; Song F; Zhang X; Yang C
    Oxid Med Cell Longev; 2022; 2022():1592905. PubMed ID: 35535359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel five-lncRNA signature panel improves high-risk survival prediction in patients with cholangiocarcinoma.
    Xie X; Wang Y; Zhang S; Li J; Yu Z; Ding X; Ye L; Gong P; Zhu Q; Li J; Chen Z; Yao X; Du Z; Zeng Q; Chen H; Yang Z; Chen G
    Aging (Albany NY); 2021 Jan; 13(2):2959-2981. PubMed ID: 33472169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting very early recurrence in intrahepatic cholangiocarcinoma after curative hepatectomy using machine learning radiomics based on CECT: A multi-institutional study.
    Chen B; Mao Y; Li J; Zhao Z; Chen Q; Yu Y; Yang Y; Dong Y; Lin G; Yao J; Lu M; Wu L; Bo Z; Chen G; Xie X
    Comput Biol Med; 2023 Dec; 167():107612. PubMed ID: 37939408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
    Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
    Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction of a novel choline metabolism-related signature to predict prognosis, immune landscape, and chemotherapy response in colon adenocarcinoma.
    Liu C; Liu D; Wang F; Liu Y; Xie J; Xie J; Xie Y
    Front Immunol; 2022; 13():1038927. PubMed ID: 36451813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiomics analysis reveals metabolic subtypes and identifies diacylglycerol kinase α (DGKA) as a potential therapeutic target for intrahepatic cholangiocarcinoma.
    Liu W; Wang H; Zhao Q; Tao C; Qu W; Hou Y; Huang R; Sun Z; Zhu G; Jiang X; Fang Y; Gao J; Wu X; Yang Z; Ping R; Chen J; Yang R; Chu T; Zhou J; Fan J; Tang Z; Yang D; Shi Y
    Cancer Commun (Lond); 2024 Feb; 44(2):226-250. PubMed ID: 38143235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Revealing the role of necroptosis microenvironment: FCGBP + tumor-associated macrophages drive primary liver cancer differentiation towards cHCC-CCA or iCCA.
    Wang C; Chen C; Hu W; Tao L; Chen J
    Apoptosis; 2024 Apr; 29(3-4):460-481. PubMed ID: 38017206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of Vein-Rich Tumor Microenvironment of Intrahepatic Cholangiocarcinoma With Tertiary Lymphoid Structures and Patient Outcome.
    Doi N; Ino Y; Fuse M; Esaki M; Shimada K; Hiraoka N
    Mod Pathol; 2024 Feb; 37(2):100401. PubMed ID: 38043787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic analysis of m6A-related lncRNAs as potential biomarkers in intrahepatic cholangiocarcinom.
    Shi G; Wang J; Wang W; Chen M; Liu X; Zheng Y; Fu Y; Wang M; Zhang X
    Front Genet; 2022; 13():982707. PubMed ID: 36160000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a necroptosis-related gene signature as a novel prognostic biomarker of cholangiocarcinoma.
    Xu L; Gao X; Xing J; Guo Z
    Front Immunol; 2023; 14():1118816. PubMed ID: 36936916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution and density of tertiary lymphoid structures predict clinical outcome in intrahepatic cholangiocarcinoma.
    Ding GY; Ma JQ; Yun JP; Chen X; Ling Y; Zhang S; Shi JY; Chang YQ; Ji Y; Wang XY; Tan WM; Yuan KF; Yan B; Zhang XM; Liang F; Zhou J; Fan J; Zeng Y; Cai MY; Gao Q
    J Hepatol; 2022 Mar; 76(3):608-618. PubMed ID: 34793865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.